← Back to Search

Health Education for Improving Health Behaviors

N/A
Recruiting
Led By Dave DeGarmo, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline attitudes towards covid-19 vaccines at 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help Latinx individuals in Oregon feel better about accepting health advice and taking actions like COVID-19 testing. The intervention involves a short exercise where participants think positively about themselves. This approach is expected to make them more open to health messages and reduce barriers like discrimination and mistrust.

Who is the study for?
This trial is for adults over the age of 18 who are attending a Mexican Consulate event that the research team is also attending. It aims to engage with Latinx communities and address COVID-19 health disparities.
What is being tested?
The study tests a behavioral intervention called Self-Affirmation Implementation Intentions (SAII) alongside Promotores de Salud, which is health education provided by community health workers, to see if they improve health behaviors and reduce vaccine hesitancy among Latinx populations.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct physical side effects expected from participating in these activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline attitudes towards covid-19 vaccines at 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline attitudes towards covid-19 vaccines at 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
COVID-19 Knowledge & Attitudes (KAPs)
Coronavirus-Related eHealth Literacy Scale (CoV-eHEALS)
Rapid Testing Acceptance
+1 more
Secondary study objectives
Broadband internalizing symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Self-Affirmation Implementation Intentions (SAII) intervention (plus Promotores Health Education)Experimental Treatment2 Interventions
The SAII is designed to reduce stigma and enhance uptake of health messaging. SAII couples; (a) self-affirming interventions that focus on restoring self-integrity in the face of identity threats, with (b) implementation intention interventions focus on whether realization of goal intentions for health behaviors is facilitated by forming an "implementation intention" that spells out when, where, and how of goal striving in advance.
Group II: Promotores Health Education only conditionActive Control1 Intervention
The Promotores de Salud Health Education intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation. When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Behavioral interventions like the Promotores de Salud COVID-19 Health Promotion Intervention with Self-Affirming Implementation Intention (SAII) work by enhancing patients' acceptance of health messages and increasing their motivation to adopt healthier behaviors. The self-affirming component helps individuals focus on their values and strengths, which reduces resistance to health advice and lowers psychological distress. This approach is crucial for health behavior patients as it not only promotes positive behavior change but also supports mental well-being, making it more likely that patients will sustain these changes over time.
Handwashing Message Type Predicts Behavioral Intentions in the United States at the Beginning of the Global COVID-19 Pandemic.Effects of a brief multimodal online intervention on the intention to conduct sun protective behaviours through targeting illness representations about skin cancer: a randomized controlled trial.

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor
85 Previous Clinical Trials
43,638 Total Patients Enrolled
4 Trials studying Health Behaviors
3,641 Patients Enrolled for Health Behaviors
National Institute on Minority Health and Health Disparities (NIMHD)NIH
429 Previous Clinical Trials
1,370,721 Total Patients Enrolled
9 Trials studying Health Behaviors
5,484 Patients Enrolled for Health Behaviors
Dave DeGarmo, PhDPrincipal InvestigatorUniversity of Oregon

Media Library

Promotores de Salud (Health Education) Clinical Trial Eligibility Overview. Trial Name: NCT05910879 — N/A
Health Behaviors Research Study Groups: Self-Affirmation Implementation Intentions (SAII) intervention (plus Promotores Health Education), Promotores Health Education only condition
Health Behaviors Clinical Trial 2023: Promotores de Salud (Health Education) Highlights & Side Effects. Trial Name: NCT05910879 — N/A
Promotores de Salud (Health Education) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05910879 — N/A
~160 spots leftby Nov 2025